The <scp>PreGen</scp> Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary

Prenatal genomic sequencing, which can provide a significantly increased diagnostic rate for fetal structural anomaly (FSA) compared with karyotype and microarray, is not available uniformly across Australia. PreGen, a 5-year translational research program, has identified significant barriers to implementation including access to funding, the availability of genomic testing, access to termination of pregnancy services and the availability of specialist genomic centres. A federal item number for prenatal genomic testing would increase equitable test availability and reduce delays to diagnoses by making them in pregnancy whilst removing the need for low-yield diagnostic interventions and enabling personalised patient management and family support.

Authors

Institutions

Publication Details

Journal
Australian and New Zealand Journal of Obstetrics and Gynaecology
Published
2025-03-24
DOI
https://doi.org/10.1111/ajo.13936
Citations
2
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
6.99

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary

Holly E. Evans, Jon Anthony Hyett, Alyssa M. Wilson, Sebastian Lunke et al.
2 citations
Australian and New Zealand Journal of Obstetrics and Gynaecology
Prenatal Screening and Diagnostics
6.99
article

The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary

Holly E. Evans, Jon Anthony Hyett, Alyssa M. Wilson, Sebastian Lunke, Claire Elizabeth Wakefield, Tony Roscioli, Hamish S. Scott, Natalie Hart, Rebecca Vink, Meaghan Wall, DEBORAH J. SCHOFIELD, Lauren Kelada, George McGillivray, Sarah S. Long, Kate Ross, Michael F. Buckley, Gemma Fernihough, Josh Kraindler
article en
2 citations

Abstract

Prenatal genomic sequencing, which can provide a significantly increased diagnostic rate for fetal structural anomaly (FSA) compared with karyotype and microarray, is not available uniformly across Australia. PreGen, a 5-year translational research program, has identified significant barriers to implementation including access to funding, the availability of genomic testing, access to termination of pregnancy services and the availability of specialist genomic centres. A federal item number for prenatal genomic testing would increase equitable test availability and reduce delays to diagnoses by making them in pregnancy whilst removing the need for low-yield diagnostic interventions and enabling personalised patient management and family support.

Australian and New Zealand Journal of Obstetrics and GynaecologyVol. 65(4)
South Australia Pathology (AU), Royal Women's Hospital (AU), UNSW Sydney (AU), Prince of Wales Hospital (AU), Victorian Clinical Genetics Services (AU), Sydney Children's Hospital (AU), Sydney Local Health District (AU), Centre for Cancer Biology (AU), Murdoch Children's Research Institute (AU), South Western Sydney Local Health District (AU), Western Sydney University (AU), Neuroscience Research Australia (AU), Macquarie University (AU)
Australian Government
Good health and well-being
Openalex Percentile: Top 5%
Prenatal Screening and Diagnostics
6.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.